Cutler Group LP Tyme Technologies, Inc. Put Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Put Options

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2022 Apr 14, 2022	SELL	$0.28 - $0.68 $280 - $680	-1,000 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$0.6 - $1.04 $300 - $520	500 Added 100.0%	1,000 $0
Q3 2021 Oct 26, 2021	SELL	$0.99 - $1.38 $1,089 - $1,517	-1,100 Reduced 68.75%	500 $2,000
Q2 2021 Jul 19, 2021	SELL	$1.14 - $1.87 $2,280 - $3,740	-2,000 Reduced 55.56%	1,600 $1,000
Q1 2021 Apr 26, 2021	BUY	$1.34 - $3.53 $3,484 - $9,178	2,600 Added 260.0%	3,600 $1,000
Q1 2020 May 07, 2020	BUY	$0.9 - $1.95 $900 - $1,950	1,000 New	1,000 $0

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.